Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
(April 1999)
Manninen S, Silvennoinen S, Bendel P, Lankinen M, Schwab US, Sankilampi U
Your PlexusDx provider uses these genetic insights alongside your lifestyle data to create a truly personalized treatment plan that avoids the trial-and-error approach
You shall avoid sun exposure for one to 3 days minimum, avoids creams, make-up and even bathing
US$ 27.43
US$ 23.01
US$ 22.73
US$ 29.71
US$ 25.07
